Headlines in Urology Treatment
Clinical advancements in the field of urology are featured in the news media every day. This section provides patients and physicians with the most up to date information on recent urologic advancements around the world.
* Please Note - TUCC does not necessarily advocate any of the treatment methods listed in the articles below. This news feed is provided as a resource for those interested in the latest urological research occurring around the world.
Healthy Lifestyle Key To Cancer Prevention
While the number of deaths from cancer have been declining, many malignancies could be prevented by exercising, eating right, maintaining a healthy weight and not smoking, a new federal report finds.
The President's Cancer Panel issues a report every year that focuses on one aspect of what is happening in the United States in terms of cancer.
| Go to storyMolecule May Predict Prostate Cancer's Return
For the first time, scientists say they have identified an immune molecule that may predict prostate cancer recurrence after surgery.
| Go to storyDiet and Prostate Cancer
One's diet is believed to play an important role in the causation of prostate cancer. Epidemiological studies, looking at different populations where the incidence of prostate cancer varies widely, suggest that differences in diet may partly account for these variations.
It is known, for example, that Asian men living in Asia have a very low incidence of prostate cancer. However, when these men migrate to America and adopt a Westernised lifestyle, within a generation, their incidence of prostate cancer approximates that of their white American counterparts.
| Go to storyEthnicity a Factor in Prostate Survival?
Prognostic factors for prostate cancer survival do not explain why most Asian-American men have better survival compared to white men, says a U.S. study.
The study, published in the Sept. 15 journal Cancer, showed that compared to white men, most Asian ethnic groups except South Asians paradoxically have better outcomes despite having worse prognostic profiles at the time of diagnosis.
Survival of second testicular cancer not lower
Men who survive testicular cancer are just as likely to survive a second cancer as men who never had testicular cancer, according to a report in the Journal of the National Cancer Institute.
About one third of testicular cancer survivors will develop a second cancer later in life, the authors explain. But it has not been known if the survival rates associated with the second cancer differs from the survival rates following the diagnosis of the first testicular cancer.
| Go to storyPreventative Care Can Save Men's Lives
Our busy lives and work schedules often prevent us from seeking routine health exams. Yet, by taking the time for routine check ups we can work with our doctors to detect, and possibly prevent serious illness.
| Go to storyFitness plays a key role in battling cancer
So. You get the worst news of your life: cancer.
You dutifully sign on for chemo, surgery, radiation. You also vow to eat better. More fruits and veggies, less saturated fat -- all that good stuff should tip the odds in your favor, right?
There's actually surprisingly little evidence that such dietary changes prolong survival -- except perhaps for colon cancer.
| Go to storyTumor-Zapping Technique Fights Kidney Cancer
A heat-based technique called "CT-guided radiofrequency ablation" was almost 100 percent successful in destroying small malignant kidney tumors in a study of more than 100 patients, new research shows.
| Go to storyFused Genes Might Fuel Prostate Tumors
U.S. researchers say they've spotted special "gene fusions" that help trigger prostate cancer.
Researchers at the University of Michigan (U-M) Comprehensive Cancer Center found that pieces of two chromosomes can trade places with each other and cause two genes to fuse together. These fused genes then override the "off" switch that prevents uncontrolled cell growth -- key to the development of prostate cancer.
| Go to storyTwo-Drug Combo Tough on Kidney Cancer
Kidney cancer might have met its match in a new combination of cancer drugs, a new study shows.
Used together, interferon alpha, a drug that boosts the body's ability to fight off tumors and infections, and sorafenib, a drug that cuts off a tumor's blood supply, led to significant tumor shrinkage in 33 percent of patients in a U.S. pilot study.
| Go to story


